免疫抑制类型与细菌性呼吸机相关性下呼吸道感染的发生率、微生物学及结局的关系:一项回顾性多中心研究
这项国际多中心回顾性队列研究纳入9个国家118个ICU的854例接受有创机械通气超过48小时的免疫抑制成人患者(中位年龄65岁,57.6%男性),其中162例为血液恶性肿瘤。主要发现:血液恶性肿瘤患者28天细菌性呼吸机相关性下呼吸道感染累积发生率为13.6%,低于其他免疫抑制类型患者的20.1%(校正病因特异性HR 0.61,95%CI 0.37-0.97),差异主要源于呼吸机相关性肺炎发生率更低(9.3% vs 13.9%)。两组中耐多药细菌相关感染比例相似。发生细菌性呼吸机相关性下呼吸道感染与死亡率升高和ICU住院时间延长相关,但该效应与免疫抑制类型无关。
要点
- 血液恶性肿瘤患者28天细菌性VALRTI累积发生率为13.6%,其他免疫抑制类型为20.1%(校正病因特异性HR 0.61,95%CI 0.37-0.97)。
- 血液恶性肿瘤患者呼吸机相关性肺炎发生率9.3%,其他免疫抑制类型为13.9%。
- 两组中耐多药细菌相关VALRTI比例相似。
- 发生细菌性VALRTI与死亡率升高和ICU住院时间延长相关,但该效应独立于免疫抑制类型。
- 研究纳入9个国家118个ICU的854例免疫抑制成人患者,其中162例为血液恶性肿瘤。
适用人群与场景
- 9个国家118个ICU中接受有创机械通气超过48小时的免疫抑制成人患者,共854例(中位年龄65岁,57.6%男性),其中162例为血液恶性肿瘤。
研究设计与关键结果
- 研究设计:国际多中心回顾性队列研究,纳入118个ICU、9个国家、854例免疫抑制成人患者,其中162例血液恶性肿瘤,无干预。
- 主要终点:血液恶性肿瘤患者28天细菌性VALRTI累积发生率为13.6%,其他免疫抑制类型为20.1%,校正病因特异性HR 0.61(95%CI 0.37-0.97)。
- 次要终点:血液恶性肿瘤患者呼吸机相关性肺炎发生率为9.3%,其他免疫抑制类型为13.9%。
- 两组中耐多药细菌相关VALRTI比例相似。
- 发生细菌性VALRTI与死亡率升高和ICU住院时间延长相关,但该效应独立于免疫抑制类型。
证据类型、等级与局限
- 证据类型:国际多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Ventilator-associated lower respiratory tract infections (VALRTIs) are among the most common ICU-acquired infections in patients receiving invasive mechanical ventilation (IMV). Immunocompromised patients may have a lower incidence of VALRTI when compared with nonimmunocompromised patients, but the influence of the type of immunosuppression on the epidemiology of VALRTI has not been investigated. The study objectives were to assess the association of the type of immunosuppression with the incidence, microbiology, and outcomes (ICU mortality, ICU length of stay, and duration of IMV) of VALRTI related to bacterial pathogens.
DESIGN: Multicenter, international retrospective cohort study.
SETTING: One hundred eighteen ICUs (118) in nine countries.
PATIENTS: Eight hundred fifty-four immunocompromised adult patients (median age, 65 yr; 57.6% males) requiring IMV for greater than 48 hours, including 162 with hematologic malignancies.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Patients with hematologic malignancies had a lower 28-day cumulative incidence of bacterial VALRTI than patients with other types of immunosuppression (13.6% vs. 20.1%; adjusted cause-specific hazard ratio, 0.61; 95% CI, 0.37-0.97), mostly due to a lower incidence of ventilator-associated pneumonia (9.3% vs. 13.9%). The proportion of VALRTI cases related to multidrug-resistant bacteria was similar between groups. Occurrence of bacterial VALRTI was associated with an increased mortality and a longer ICU length of stay, but this effect was independent of the type of immunosuppression.
CONCLUSIONS: Patients with hematologic malignancies had a lower 28-day cumulative incidence of bacterial VALRTI than patients with other types of immunosuppression, mainly due to a lower incidence of ventilator-associated pneumonia.
参考来源
- Kreitmann L, Bayon C, Martin-Loeches I, et al. Association Between Type of Immunosuppression and the Incidence, Microbiology, and Outcomes of Bacterial Ventilator-Associated Lower Respiratory Tract Infections: A Retrospective Multicenter Study. Crit Care Med. 2025. PMID: 39982132. doi:10.1097/CCM.0000000000006615
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。